WINNING STRATEGIES WASHINGTON for NATIONAL FRAGILE X FOUNDATION
No amount is shown when the filer reports less than $5,000 for the period, which the form does not ask them to state.
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Legislation directly impacting disability and rare disease communities; Issues around the funding of rare disease research
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH CONNOLLY | Assistant Director of Public Health, Office of National Drug Control Policy |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli |
| DONNA MULLINS | CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa |
Budget/Appropriations BUD
Funding for Fragile X and related initiates
| Lobbyist | Covered position, as disclosed |
|---|---|
| ELIZABETH CONNOLLY | Assistant Director of Public Health, Office of National Drug Control Policy |
| MICHAEL A MEROLA | Deputy CoS, Sen. Torricelli |
| DONNA MULLINS | CoS/Approps Staff, Rep. Frelinghuysen and Rep. Dean Gallo; CoS Senator Chiesa |
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.